August 13, 2024 02:21 PM EDT
Pharma
Law

IRA price ne­go­ti­a­tion re­sults to be re­leased Thurs­day — re­port

Drew Armstrong

Executive Editor

The Biden ad­min­is­tra­tion plans to share at least some re­sults of IRA drug price ne­go­ti­a­tions on Thurs­day, ac­cord­ing to a Politi­co re­port that cit­ed anony­mous …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Take­da to pay $200M for rights to ane­mia drug from Keros

Janux soars on ear­ly prostate can­cer da­ta that could chal­lenge No­var­tis' Plu­vic­to

Rev­o­lu­tion sells $600M in shares on back of RAS in­hibitor port­fo­lio up­dates

Roche teams up with Chica­go au­toim­mune biotech COUR Phar­ma­ceu­ti­cals

Ipsen se­cures rights to pre­clin­i­cal T cell en­gager in $610M pact with French biotech

Gilead makes an­oth­er ADC move, ink­ing up to $415M pact with Tubu­lis

A service from the Financial Times